Anaphylaxis

WASHINGTON — Epinephrine formulated as nasal powder demonstrated superior stability compared with autoinjector epinephrine, according to an abstract presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

WASHINGTON — An epinephrine nasal spray resulted in outcomes that were comparable with injections in pediatric patients, according to a poster presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

The FDA has approved Xolair for the reduction of allergic reactions in children and adults with immunoglobulin E-mediated food allergy, according to a press release from Roche.

In the hype leading up to this year’s Super Bowl, Uber Eats released a preview of its Big Game commercial. Along with appearances from Jennifer Aniston, Usher and other celebrities, it included a joke about a man with a peanut allergy.

The FDA has approved Xolair for the reduction of allergic reactions, including anaphylaxis, that may occur with exposure to one or more foods in children and adults with Immunoglobulin E-mediated food allergy.

Children who experienced food-induced anaphylaxis before age 3 years had greater odds for developing eating and sleeping disorders that could persist into adulthood, according to a study published in Pediatric Allergy and Immunology.

Adults with food allergies experienced limited success with oral immunotherapy, according to results of a small cohort study.

ARS Pharma continues to study the effectiveness and safety of its neffy epinephrine nasal spray as patients with allergies wait for an alternative to autoinjectors for anaphylaxis treatment.

Healio compiled the most-read news in allergy, asthma and immunology posted in January.

A joint task force has published an updated, evidence-based practice parameter for diagnosing and treating anaphylaxis in Annals of Allergy, Asthma & Immunology.